Cargando…
Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD
OBJECTIVES: Develop an individualised prognostic risk prediction tool for predicting the probability of adverse COVID-19 outcomes in patients with inflammatory bowel disease (IBD). DESIGN AND SETTING: This study developed and validated prognostic penalised logistic regression models using reports to...
Autores principales: | Sperger, John, Shah, Kushal S, Lu, Minxin, Zhang, Xian, Ungaro, Ryan C, Brenner, Erica J, Agrawal, Manasi, Colombel, Jean-Frédéric, Kappelman, Michael D, Kosorok, Michael R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593277/ https://www.ncbi.nlm.nih.gov/pubmed/34772750 http://dx.doi.org/10.1136/bmjopen-2021-049740 |
Ejemplares similares
-
Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients
por: Sperger, John, et al.
Publicado: (2021) -
Fr491 MULTIVARIABLE PREDICTION MODELS FOR HOSPITALIZATION, VENTILATION, AND DEATH FROM COVID-19 IN IBD PATIENTS
por: Sperger, John, et al.
Publicado: (2021) -
Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021) -
The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD
Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021) -
Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)